Skip to main content

Industry News

Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.

Cerilliant Expands With Move to Round Rock

Published 3/12/2002

Cerilliant Corp., a provider of chemical services and samples, is expanding its operations with a move to Round Rock, Texas, from Austin. Currently housed in a cramped 12,000 sf, Cerilliant will occupy 32,000 sf of the 40,000-sf AmorRon 3 building. Slated for late April, the move will involve substantial improvements including construction of an extensive laboratory facility. The relocation was prompted by a need for more space to accommodate current and projected company growth.

Read More

Howard Hughes Medical Institute Designs Research Campus

Published 3/7/2002

The Howard Hughes Medical Institute, based in Chevy Chase, Md., has selected Rafael Vinoly Architects of New York to design its planned $500-million Loudon County research campus at Janelia Farm. The 750,000-sf project will accommodate research labs, conference facilities, and will provide more than 100 visitors with dormitory housing. Scientific staff at the complex is expected to reach 200. Construction is scheduled to begin in 2003, with completion in early 2006.

Read More

Incyte Genomics Seeks East Coast Facility

Published 3/7/2002

Incyte Genomics Inc., based in Palo Alto, Calif., will move into 53,100 sf at DuPont’s Stine-Haskell Research Center in Newark while the biotech company searches for a permanent East Coast facility for its therapeutic discovery and development work. Incyte hopes to secure approximately 90,000 sf of research, lab, and office space to accommodate 140 R&D staff in the next two years, and a total of 200 employees by 2005. Biotech and pharmaceutical companies, as well as research and academic institutions, use Incyte’s genomics technologies and products.

Read More

Amgen Considers RTP Location for R&D Project

Published 3/7/2002

Amgen, based in Thousand Oaks, Calif., is considering locations in Research Triangle Park for a new $500-million, 250,000-sf facility. The project would include at least 250,000 sf for biological manufacturing, clinical, and development operations. The biotech company is expanding at its other locations as well. A 92,000-sf research center opened in Cambridge, Mass., late last year; two drug R&D buildings and a parking garage are being added in Thousand Oaks; and the company plans to expand manufacturing at its 232-acre site in Longmont, Colo.

Read More